[ET Net News Agency, 7 March 2024] CSTONE PHARMA-B (02616) fell 15.2% to HK$0.89.
It hits an intra-day low of HK$0.89, hitting a historical low, and an intra-day high of
HK$1.06. The total shares traded was 7.37 million, with a value of HK$6.95m. The active
buy/sell ratio is 30:70, with net selling turnover of HK$2.75m. JEFFERIES HK accounts for
greatest net responsive buying turnover of HK$1.06m, with volume weighted average price of
HK$0.944. CHINA INNOVATION MARKET SER accounts for greatest net responsive selling
turnover of HK$664,997, with volume weighted average price of HK$0.95. The stock has
fallen a combined 44.4% over the past 5 consecutive trading days.

Basic Information
=================

---------------------------------
Nominal 0.890 % Chg -15.24%
High 1.060 Low 0.890
Shares Tr 7.37m Turnover 6.95m
10-D SMA 1.372 %H.V 116.790
20-D SMA 1.464 VWAP 0.943
50-D SMA 1.765 RSI14 18.476
---------------------------------
Status: Hitting a historical low, active buy/sell ratio is 30:70, with net selling
turnover of HK$2.75m, falling a combined 44.4% over the past 5 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
CSTONE PHARMA-B (02616) 0.89 -15.24
GENSCRIPT BIO (01548) 14.28 -5.68
INNOVENT BIO (01801) 38.40 -0.90
EVEREST MED-B (01952) 25.50 +0.99
LAEKNA-B (02105) 6.97 -15.41
WUXI XDC (02268) 20.55 -11.42
WUXI BIO (02269) 17.04 -21.66
TIGERMED (03347) 24.80 -7.64
AKESO (09926) 44.55 -1.00
REMEGEN (09995) 21.40 -8.15
-----------------------------------------------
(ed)